[Antibiotic therapy of severe community-acquired pneumonia].
Combined antibiotic therapy, including the use of intravenous cefotaxime (a beta-lactam) and azithromycin (a macrolide) was shown advantageous from both clinical and economic viewpoints in the treatment of severe community-acquired pneumonia.
Molchanova
O V
OV
Suleĭmanov
S Sh
SSh
Ostrovskiĭ
A B
AB
D000368:Aged; D000900:Anti-Bacterial Agents / Q000191:economics* / Q000627:therapeutic use; D017963:Azithromycin / Q000191:economics* / Q000627:therapeutic use; D002439:Cefotaxime / Q000191:economics* / Q000627:therapeutic use; D017714:Community-Acquired Infections / Q000188:drug therapy* / Q000191:economics*; D003365:Costs and Cost Analysis; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D007902:Length of Stay / Q000191:economics; D008297:Male; D008499:Medical Records; D008875:Middle Aged; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D017963:Azithromycin; D002439:Cefotaxime